Harvard Bioscience (HBIO) Short Interest Ratio & Short Volume

Short interest is the volume of Harvard Bioscience shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 673,000 shares of HBIO short. Learn More on Harvard Bioscience's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HBIO shares currently have a short interest ratio of 8.0. Learn More on Harvard Bioscience's short interest ratio.

Harvard Bioscience saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 673,000 shares, an increase of 5.7% from the previous total of 636,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Harvard Bioscience: OptimizeRx Co. (3.92%), VOXX International Co. (2.84%), Innodata Inc. (10.68%), AudioEye, Inc. (3.35%), Rekor Systems, Inc. (12.00%), Geospace Technologies Co. (1.81%), Baozun Inc. (3.45%), QuickLogic Co. (9.67%), Atomera Incorporated (17.88%), trivago (0.28%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling HBIO is an investing strategy that aims to generate trading profit from Harvard Bioscience as its price is falling. HBIO shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Harvard Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of HBIO, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HBIO, twice per month. The most recent reporting period available is April, 15 2024.